Form 8-K - Current report:
SEC Accession No. 0001193125-25-163860
Filing Date
2025-07-24
Accepted
2025-07-24 08:15:51
Documents
14
Period of Report
2025-07-22
Items
Item 5.02: Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements of Certain Officers
Item 7.01: Regulation FD Disclosure
Item 9.01: Financial Statements and Exhibits

Document Format Files

Seq Description Document Type Size
1 8-K d862655d8k.htm   iXBRL 8-K 26853
2 EX-99.1 d862655dex991.htm EX-99.1 7138
6 GRAPHIC g862655g0723211523124.jpg GRAPHIC 2780
  Complete submission text file 0001193125-25-163860.txt   155666

Data Files

Seq Description Document Type Size
3 XBRL TAXONOMY EXTENSION SCHEMA bhc-20250722.xsd EX-101.SCH 2520
4 XBRL TAXONOMY EXTENSION LABEL LINKBASE bhc-20250722_lab.xml EX-101.LAB 17912
5 XBRL TAXONOMY EXTENSION PRESENTATION LINKBASE bhc-20250722_pre.xml EX-101.PRE 11230
16 EXTRACTED XBRL INSTANCE DOCUMENT d862655d8k_htm.xml XML 3711
Mailing Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8
Business Address 2150 ST. ELZEAR BLVD. WEST LAVAL QUEBEC A8 H7L 4A8 514-744-6792
Bausch Health Companies Inc. (Filer) CIK: 0000885590 (see all company filings)

EIN.: 000000000 | State of Incorp.: NJ | Fiscal Year End: 1231
Type: 8-K | Act: 34 | File No.: 001-14956 | Film No.: 251144592
SIC: 2834 Pharmaceutical Preparations
(CF Office: 03 Life Sciences)